1. Home
  2. RGEN vs MKSI Comparison

RGEN vs MKSI Comparison

Compare RGEN & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • MKSI
  • Stock Information
  • Founded
  • RGEN 1981
  • MKSI 1961
  • Country
  • RGEN United States
  • MKSI United States
  • Employees
  • RGEN N/A
  • MKSI N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • MKSI Industrial Machinery/Components
  • Sector
  • RGEN Health Care
  • MKSI Industrials
  • Exchange
  • RGEN Nasdaq
  • MKSI Nasdaq
  • Market Cap
  • RGEN 9.2B
  • MKSI 9.6B
  • IPO Year
  • RGEN N/A
  • MKSI 1999
  • Fundamental
  • Price
  • RGEN $147.07
  • MKSI $104.43
  • Analyst Decision
  • RGEN Buy
  • MKSI Strong Buy
  • Analyst Count
  • RGEN 10
  • MKSI 8
  • Target Price
  • RGEN $188.38
  • MKSI $146.63
  • AVG Volume (30 Days)
  • RGEN 871.2K
  • MKSI 751.7K
  • Earning Date
  • RGEN 10-29-2024
  • MKSI 10-30-2024
  • Dividend Yield
  • RGEN N/A
  • MKSI 0.84%
  • EPS Growth
  • RGEN N/A
  • MKSI N/A
  • EPS
  • RGEN N/A
  • MKSI 0.12
  • Revenue
  • RGEN $602,354,000.00
  • MKSI $3,580,000,000.00
  • Revenue This Year
  • RGEN $0.05
  • MKSI N/A
  • Revenue Next Year
  • RGEN $12.97
  • MKSI $10.00
  • P/E Ratio
  • RGEN N/A
  • MKSI $878.36
  • Revenue Growth
  • RGEN N/A
  • MKSI N/A
  • 52 Week Low
  • RGEN $110.45
  • MKSI $63.44
  • 52 Week High
  • RGEN $211.13
  • MKSI $147.40
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 48.18
  • MKSI 37.12
  • Support Level
  • RGEN $139.41
  • MKSI $105.29
  • Resistance Level
  • RGEN $152.92
  • MKSI $110.61
  • Average True Range (ATR)
  • RGEN 5.53
  • MKSI 4.54
  • MACD
  • RGEN -1.29
  • MKSI -0.90
  • Stochastic Oscillator
  • RGEN 43.82
  • MKSI 2.40

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About MKSI MKS Instruments Inc.

MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue, and the majority of its revenue is earned in the United States.

Share on Social Networks: